Skip to content

Released Aug 2, 2022, after the close

10-Q filed Aug 3, 2022, 34 days after period end · 0001653477-22-000032

Q2 2022 · 10-Q
Revenue$419.90M+17.2% vs Q2 2021+9.7% vs Q1 2022
Net Income$59.80M+35.0% vs Q2 2021−1.6% vs Q1 2022
EPS Diluted$1.54+40.0% vs Q2 2021−0.6% vs Q1 2022
Gross Profit$150,600,000+7.7%
Operating Income$121,100,000+2.9%
Operating Cash Flowderived$90,500,000+37.5%
Free Cash Flowderived$60,900,000+45.3%
Margins · derived
Gross margin35.9%−3.1 pt vs Q2 2021
Operating margin28.8%−4.0 pt vs Q2 2021
Net margin14.2%+1.9 pt vs Q2 2021

What the release said

The release

Same quarter

MetricQ2 2022Q2 2021Q2 2020Q2 2019
Revenue$419.90M$358.40M$270.60M$352.80M
Net Income$59.80M$44.30M$20.20M$56.80M
EPS Diluted$1.54$1.10$0.49$1.34

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR